The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t(9;22] that gives rise to a BCR-ABL1 fusion gene. CML occurs in 3 different phases (chronic, accelerated, and blast phase) and is usually diagnosed in the chronic phase. Tyrosine kinase inhibitor therapy is a highly effective first-line treatment option for all patients with newly diagnosed chronic phase CML. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with chronic phase CML.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Self-citationSawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,621
Mahon, F.-X., Réa, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., Legros, L., Charbonnier, A., Guerci, A., Varet, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70233-3 · Cited by 1,550
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547
Self-citationGranulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
The Biology of Chronic Myeloid Leukemia
Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,302
Self-citationLong-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Hochhaus, A., Larson, R. A., Guilhot, F., Radich, J. P., Branford, S., Hughes, T. P., Baccarani, M., Deininger, M. W., Cervantes, F., Fujihara, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609324 · Cited by 1,285
Self-citationPrognostic discrimination in "good-risk" chronic granulocytic leukemia
Sokal, J., Cox, E., Baccarani, M., Tura, S., Gomez, G., Robertson, J., Tso, C., Braun, T., Clarkson, B., & Cervantes, F. (1984) · Blood · doi:10.1182/blood.v63.4.789.789 · Cited by 1,214
Hughes, T. (2006) · Blood · doi:10.1182/blood-2006-01-0092 · Cited by 1,199
Cortes, J. E., Saglio, G., Kantarjian, H. M., Baccarani, M., Mayer, J., Boqué, C., Shah, N. P., Chuah, C., Casanova, L., Bradley-Garelik, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.8899 · Cited by 947
Self-citationMarin, D., Bazeos, A., Mahon, F.-X., Eliasson, L., Milojkovic, D., Bua, M., Apperley, J. F., Szydlo, R., Desai, R., Kozlowski, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3087 · Cited by 909
Hochhaus, A., O'Brien, S. G., Guilhot, F., Druker, B. J., Branford, S., Foroni, L., Goldman, J. M., Müller, M. C., Radich, J. P., Rudoltz, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.38 · Cited by 856
Hochhaus, A., Saglio, G., Hughes, T. P., Larson, R. A., Kim, D.-W., Issaragrisil, S., le Coutre, P. D., Etienne, G., Dorlhiac-Llacer, P. E., Clark, R. E., et al. (2016) · Leukemia · doi:10.1038/leu.2016.5 · Cited by 839
Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N. C., Baccarani, M., Kluin-Nelemans, J. C., Alimena, G., Steegmann, J. L., & Ansari, H. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.850 · Cited by 819
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
Cortes, J. E., Kantarjian, H., Shah, N. P., Bixby, D., Mauro, M. J., Flinn, I., O'Hare, T., Hu, S., Narasimhan, N. I., Rivera, V. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205127 · Cited by 769
Self-citationBranford, S., Rudzki, Z., Walsh, S., Parkinson, I., Grigg, A., Szer, J., Taylor, K., Herrmann, R., Seymour, J. F., Arthur, C., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2896 · Cited by 765
Melo, J. (1996) · Blood · doi:10.1182/blood.v88.7.2375.bloodjournal8872375 · Cited by 723
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 659
Active transport of imatinib into and out of cells: implications for drug resistance
Thomas, J., Wang, L., Clark, R. E., & Pirmohamed, M. (2004) · Blood · doi:10.1182/blood-2003-12-4276 · Cited by 643
Larson, R. A., Druker, B. J., Guilhot, F., O'Brien, S. G., Riviere, G. J., Krahnke, T., Gathmann, I., & Wang, Y. (2008) · Blood · doi:10.1182/blood-2007-10-116475 · Cited by 643
Saussele, S., Richter, J., Guilhot, J., Gruber, F. X., Hjorth-Hansen, H., Almeida, A., Janssen, J. J. W. M., Mayer, J., Koskenvesa, P., Panayiotidis, P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30192-x · Cited by 618
Noens, L., van Lierde, M.-A., De Bock, R., Verhoef, G., Zachée, P., Berneman, Z., Martiat, P., Mineur, P., Van Eygen, K., MacDonald, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-196543 · Cited by 616
Picard, S., Titier, K., Etienne, G., Teilhet, E., Ducint, D., Bernard, M.-A., Lassalle, R., Marit, G., Reiffers, J., Begaud, B., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036012 · Cited by 612
Cortes, J. E., Kim, D.-W., Pinilla-Ibarz, J., le Coutre, P. D., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., et al. (2018) · Blood · doi:10.1182/blood-2016-09-739086 · Cited by 592
Self-citationGene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
Self-citationde Lavallade, H., Apperley, J. F., Khorashad, J. S., Milojkovic, D., Reid, A. G., Bua, M., Szydlo, R., Olavarria, E., Kaeda, J., Goldman, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8154 · Cited by 551
Soverini, S., Colarossi, S., Gnani, A., Rosti, G., Castagnetti, F., Poerio, A., Iacobucci, I., Amabile, M., Abruzzese, E., Orlandi, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1516 · Cited by 511
Etienne, G., Guilhot, J., Rea, D., Rigal-Huguet, F., Nicolini, F., Charbonnier, A., Guerci-Bresler, A., Legros, L., Varet, B., Gardembas, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2914 · Cited by 496
Cortes, J. E., Gambacorti-Passerini, C., Deininger, M. W., Mauro, M. J., Chuah, C., Kim, D.-W., Dyagil, I., Glushko, N., Milojkovic, D., le Coutre, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.7162 · Cited by 495
Self-citationHughes, T. P., Hochhaus, A., Branford, S., Müller, M. C., Kaeda, J. S., Foroni, L., Druker, B. J., Guilhot, F., Larson, R. A., O'Brien, S. G., et al. (2010) · Blood · doi:10.1182/blood-2010-03-273979 · Cited by 489
Biernaux, C., Loos, M., Sels, A., Huez, G., & Stryckmans, P. (1995) · Blood · doi:10.1182/blood.v86.8.3118.3118 · Cited by 485
Marin, D., Ibrahim, A. R., Lucas, C., Gerrard, G., Wang, L., Szydlo, R. M., Clark, R. E., Apperley, J. F., Milojkovic, D., Bua, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.6565 · Cited by 476
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
Hughes, T. P., Mauro, M. J., Cortes, J. E., Minami, H., Rea, D., DeAngelo, D. J., Breccia, M., Goh, Y.-T., Talpaz, M., Hochhaus, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902328 · Cited by 471
Self-citationBose, S., Deininger, M., Gora-Tybor, J., Goldman, J. M., & Melo, J. V. (1998) · Blood · doi:10.1182/blood.v92.9.3362 · Cited by 463
Self-citationWhite, D. L., Saunders, V. A., Dang, P., Engler, J., Zannettino, A. C. W., Cambareri, A. C., Quinn, S. R., Manley, P. W., & Hughes, T. P. (2006) · Blood · doi:10.1182/blood-2005-11-4687 · Cited by 435
Rousselot, P., Charbonnier, A., Cony-Makhoul, P., Agape, P., Nicolini, F. E., Varet, B., Gardembas, M., Etienne, G., Réa, D., Roy, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5797 · Cited by 416
Hanfstein, B., Müller, M. C., Hehlmann, R., Erben, P., Lauseker, M., Fabarius, A., Schnittger, S., Haferlach, C., Göhring, G., Proetel, U., et al. (2012) · Leukemia · doi:10.1038/leu.2012.85 · Cited by 415
The effects of imatinib on pregnancy outcome
Pye, S. M., Cortes, J., Ault, P., Hatfield, A., Kantarjian, H., Pilot, R., Rosti, G., & Apperley, J. F. (2008) · Blood · doi:10.1182/blood-2007-10-114900 · Cited by 395
Branford, S., Fletcher, L., Cross, N. C. P., Müller, M. C., Hochhaus, A., Kim, D.-W., Radich, J. P., Saglio, G., Pane, F., Kamel-Reid, S., et al. (2008) · Blood · doi:10.1182/blood-2008-04-150680 · Cited by 388
Standardized definitions of molecular response in chronic myeloid leukemia
Cross, N. C. P., White, H. E., Müller, M. C., Saglio, G., & Hochhaus, A. (2012) · Leukemia · doi:10.1038/leu.2012.104 · Cited by 378
Vignetti, M., Fazi, P., Cimino, G., Martinelli, G., Di Raimondo, F., Ferrara, F., Meloni, G., Ambrosetti, A., Quarta, G., Pagano, L., et al. (2007) · Blood · doi:10.1182/blood-2006-10-052746 · Cited by 374
Soverini, S., Martinelli, G., Rosti, G., Bassi, S., Amabile, M., Poerio, A., Giannini, B., Trabacchi, E., Castagnetti, F., Testoni, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.531 · Cited by 374
Zabriskie, M. S., Eide, C. A., Tantravahi, S. K., Vellore, N. A., Estrada, J., Nicolini, F. E., Khoury, H. J., Larson, R. A., Konopleva, M., Cortes, J. E., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.006 · Cited by 363
Self-citationfor the SAKK and the German CML Study Group, Hehlmann, R., Lauseker, M., Saußele, S., Pfirrmann, M., Krause, S., Kolb, H. J., Neubauer, A., Hossfeld, D. K., Nerl, C., et al. (2017) · Leukemia · doi:10.1038/leu.2017.253 · Cited by 341
Marin, D., Milojkovic, D., Olavarria, E., Khorashad, J. S., de Lavallade, H., Reid, A. G., Foroni, L., Rezvani, K., Bua, M., Dazzi, F., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162388 · Cited by 328
Khoury, H. J., Cortes, J. E., Kantarjian, H. M., Gambacorti-Passerini, C., Baccarani, M., Kim, D.-W., Zaritskey, A., Countouriotis, A., Besson, N., Leip, E., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390120 · Cited by 324
Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate
Berman, E., Nicolaides, M., Maki, R. G., Fleisher, M., Chanel, S., Scheu, K., Wilson, B.-A., Heller, G., & Sauter, N. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051140 · Cited by 319
Self-citationRea, D., Nicolini, F. E., Tulliez, M., Guilhot, F., Guilhot, J., Guerci-Bresler, A., Gardembas, M., Coiteux, V., Guillerm, G., Legros, L., et al. (2017) · Blood · doi:10.1182/blood-2016-09-742205 · Cited by 317
Ibrahim, A. R., Eliasson, L., Apperley, J. F., Milojkovic, D., Bua, M., Szydlo, R., Mahon, F.-X., Kozlowski, K., Paliompeis, C., Foroni, L., et al. (2011) · Blood · doi:10.1182/blood-2010-10-309807 · Cited by 316
Pfirrmann, M., Baccarani, M., Saussele, S., Guilhot, J., Cervantes, F., Ossenkoppele, G., Hoffmann, V. S., Castagnetti, F., Hasford, J., Hehlmann, R., et al. (2016) · Leukemia · doi:10.1038/leu.2015.261 · Cited by 307
Hughes, T., Saglio, G., Branford, S., Soverini, S., Kim, D.-W., Müller, M. C., Martinelli, G., Cortes, J., Beppu, L., Gottardi, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8230 · Cited by 306
Kantarjian, H. M., Talpaz, M., O'Brien, S., Giles, F., Garcia-Manero, G., Faderl, S., Thomas, D., Shan, J., Rios, M. B., & Cortes, J. (2003) · Blood · doi:10.1182/blood-2002-05-1451 · Cited by 306
Self-citationHehlmann, R., Müller, M. C., Lauseker, M., Hanfstein, B., Fabarius, A., Schreiber, A., Proetel, U., Pletsch, N., Pfirrmann, M., Haferlach, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.9020 · Cited by 300
Aichberger, K. J., Herndlhofer, S., Schernthaner, G., Schillinger, M., Mitterbauer‐Hohendanner, G., Sillaber, C., & Valent, P. (2011) · American Journal of Hematology · doi:10.1002/ajh.22037 · Cited by 296
Müller, M. C., Cortes, J. E., Kim, D.-W., Druker, B. J., Erben, P., Pasquini, R., Branford, S., Hughes, T. P., Radich, J. P., Ploughman, L., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214221 · Cited by 290
Fabarius, A., Leitner, A., Hochhaus, A., Müller, M. C., Hanfstein, B., Haferlach, C., Göhring, G., Schlegelberger, B., Jotterand, M., Reiter, A., et al. (2011) · Blood · doi:10.1182/blood-2011-08-373902 · Cited by 288
Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective
van Leeuwen, R. W. F., van Gelder, T., Mathijssen, R. H. J., & Jansman, F. G. A. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70579-5 · Cited by 279
Hoffmann, V. S., Baccarani, M., Hasford, J., Lindoerfer, D., Burgstaller, S., Sertic, D., Costeas, P., Mayer, J., Indrak, K., Everaus, H., et al. (2015) · Leukemia · doi:10.1038/leu.2015.73 · Cited by 256
Giles, F. J., le Coutre, P. D., Pinilla-Ibarz, J., Larson, R. A., Gattermann, N., Ottmann, O. G., Hochhaus, A., Radich, J. P., Saglio, G., Hughes, T. P., et al. (2013) · Leukemia · doi:10.1038/leu.2012.181 · Cited by 251
Ilander, M., Olsson-Strömberg, U., Schlums, H., Guilhot, J., Brück, O., Lähteenmäki, H., Kasanen, T., Koskenvesa, P., Söderlund, S., Höglund, M., et al. (2017) · Leukemia · doi:10.1038/leu.2016.360 · Cited by 250
Cortes, J. E., Talpaz, M., Giles, F., O'Brien, S., Rios, M. B., Shan, J., Garcia-Manero, G., Faderl, S., Thomas, D. A., Wierda, W., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2790 · Cited by 236
Self-citationPregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
Ault, P., Kantarjian, H., O'Brien, S., Faderl, S., Beran, M., Rios, M. B., Koller, C., Giles, F., Keating, M., Talpaz, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6557 · Cited by 233
Self-citationHegedűs, C., Özvegy‐Laczka, C., Apáti, Á., Magócsi, M., Német, K., Őrfi, L., Kéri, G., Katona, M., Takáts, Z., Váradi, A., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00383.x · Cited by 228
Khorashad, J. S., Kelley, T. W., Szankasi, P., Mason, C. C., Soverini, S., Adrian, L. T., Eide, C. A., Zabriskie, M. S., Lange, T., Estrada, J. C., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431379 · Cited by 222
Self-citationBumm, T., Müller, C., Al-Ali, H.-K., Krohn, K., Shepherd, P., Schmidt, E., Leiblein, S., Franke, C., Hennig, E., Friedrich, T., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2053 · Cited by 221
Self-citationGiles, F. J., Mauro, M. J., Hong, F., Ortmann, C.-E., McNeill, C., Woodman, R. C., Hochhaus, A., le Coutre, P. D., & Saglio, G. (2013) · Leukemia · doi:10.1038/leu.2013.69 · Cited by 216
Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression
Mahon, F.-X., Hayette, S., Lagarde, V., Belloc, F., Turcq, B., Nicolini, F., Belanger, C., Manley, P. W., Leroy, C., Etienne, G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1008 · Cited by 212
Branford, S., Wang, P., Yeung, D. T., Thomson, D., Purins, A., Wadham, C., Shahrin, N. H., Marum, J. E., Nataren, N., Parker, W. T., et al. (2018) · Blood · doi:10.1182/blood-2018-02-832253 · Cited by 210
Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Hiwase, D. K., Saunders, V., Hewett, D., Frede, A., Zrim, S., Dang, P., Eadie, L., To, L. B., Melo, J., Kumar, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5095 · Cited by 208
Age and d PCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
Mori, S., Vagge, E., le Coutre, P., Abruzzese, E., Martino, B., Pungolino, E., Elena, C., Pierri, I., Assouline, S., D'Emilio, A., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.24120 · Cited by 207
Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
Quintás-Cardama, A., Han, X., Kantarjian, H., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2008-09-180604 · Cited by 207
Nicolini, F. E., Corm, S., Lê, Q.-H., Sorel, N., Hayette, S., Bories, D., Leguay, T., Roy, L., Giraudier, S., Tulliez, M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404236 · Cited by 207
Branford, S., Yeung, D. T., Parker, W. T., Roberts, N. D., Purins, L., Braley, J. A., Altamura, H. K., Yeoman, A. L., Georgievski, J., Jamison, B. A., et al. (2014) · Blood · doi:10.1182/blood-2014-03-566323 · Cited by 202
Wang, W., Cortes, J. E., Tang, G., Khoury, J. D., Wang, S., Bueso-Ramos, C. E., DiGiuseppe, J. A., Chen, Z., Kantarjian, H. M., Medeiros, L. J., et al. (2016) · Blood · doi:10.1182/blood-2016-01-690230 · Cited by 198
Branford, S., Cross, N. C. P., Hochhaus, A., Radich, J., Saglio, G., Kaeda, J., Goldman, J., & Hughes, T. (2006) · Leukemia · doi:10.1038/sj.leu.2404388 · Cited by 196
Clark, R. E., Polydoros, F., Apperley, J. F., Milojkovic, D., Rothwell, K., Pocock, C., Byrne, J., de Lavallade, H., Osborne, W., Robinson, L., et al. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30094-8 · Cited by 195
Dewald, G. W., Wyatt, W. A., Juneau, A. L., Carlson, R. O., Zinsmeister, A. R., Jalal, S. M., Spurbeck, J. L., & Silver, R. T. (1998) · Blood · doi:10.1182/blood.v91.9.3357 · Cited by 190
Soverini, S., Colarossi, S., Gnani, A., Castagnetti, F., Rosti, G., Bosi, C., Paolini, S., Rondoni, M., Piccaluga, P. P., Palandri, F., et al. (2007) · Haematologica · doi:10.3324/haematol.10822 · Cited by 189
Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
Soverini, S., Branford, S., Nicolini, F. E., Talpaz, M., Deininger, M. W. N., Martinelli, G., Müller, M. C., Radich, J. P., & Shah, N. P. (2014) · Leukemia Research · doi:10.1016/j.leukres.2013.09.011 · Cited by 185
Self-citationThe Cytogenetic Scenario of Chronic Myeloid Leukemia
Mitelman, F. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309047856 · Cited by 184
Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Series
Bergeron, A., Réa, D., Levy, V., Picard, C., Meignin, V., Tamburini, J., Bruzzoni-Giovanelli, H., Calvo, F., Tazi, A., & Rousselot, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-715cr · Cited by 184
Khorashad, J. S., de Lavallade, H., Apperley, J. F., Milojkovic, D., Reid, A. G., Bua, M., Szydlo, R., Olavarria, E., Kaeda, J., Goldman, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9953 · Cited by 183
Verma, D., Kantarjian, H. M., Jones, D., Luthra, R., Borthakur, G., Verstovsek, S., Rios, M. B., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2009-02-204693 · Cited by 181
Shah, N. P., Rousselot, P., Schiffer, C., Rea, D., Cortes, J. E., Milone, J., Mohamed, H., Healey, D., Kantarjian, H., Hochhaus, A., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24423 · Cited by 181
Self-citationGrossmann, V, Kohlmann, A., Zenger, M., Schindela, S., Eder, C., Weissmann, S., Schnittger, S., Kern, W., Müller, M. C., Hochhaus, A., et al. (2011) · Leukemia · doi:10.1038/leu.2010.298 · Cited by 180
Soverini, S., Gnani, A., Colarossi, S., Castagnetti, F., Abruzzese, E., Paolini, S., Merante, S., Orlandi, E., de Matteis, S., Gozzini, A., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197186 · Cited by 175
Burchert, A., Müller, M. C., Kostrewa, P., Erben, P., Bostel, T., Liebler, S., Hehlmann, R., Neubauer, A., & Hochhaus, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5075 · Cited by 174
Lee, S.-E., Choi, S. Y., Song, H.-Y., Kim, S.-H., Choi, M.-Y., Park, J. S., Kim, H.-J., Kim, S.-H., Zang, D. Y., Oh, S., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.139899 · Cited by 166
Dorer, D. J., Knickerbocker, R. K., Baccarani, M., Cortes, J. E., Hochhaus, A., Talpaz, M., & Haluska, F. G. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.07.007 · Cited by 166
Self-citationGarg, R. J., Kantarjian, H., O'Brien, S., Quintás-Cardama, A., Faderl, S., Estrov, Z., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2009-05-221531 · Cited by 164
Imatinib mesylate causes hypopigmentation in the skin
Tsao, A. S., Kantarjian, H., Cortes, J., O'Brien, S., & Talpaz, M. (2003) · Cancer · doi:10.1002/cncr.11812 · Cited by 161
Self-citationSchmidt, M., Rinke, J., Schäfer, V., Schnittger, S., Kohlmann, A., Obstfelder, E., Kunert, C., Ziermann, J., Winkelmann, N., Eigendorff, E., et al. (2014) · Leukemia · doi:10.1038/leu.2014.272 · Cited by 156
Jabbour, E. J., Kantarjian, H. M., Jones, D. M., Shan, J., O'Brien, S. M., Reddy, N., Wierda, W. G., Faderl, S. H., Garcia‐Manero, G., Verstovšek, S., et al. (2008) · Blood · doi:10.1182/blood-2008-04-154344 · Cited by 155
Jain, P., Kantarjian, H. M., Patel, K. P., González, G. N., Luthra, R., Kanagal‐Shamanna, R., Sasaki, K., Jabbour, E. J., Romo, C. G., Kadia, T. M., et al. (2016) · Blood · doi:10.1182/blood-2015-10-674242 · Cited by 155
Efficace, F., Baccarani, M., Breccia, M., Cottone, F., Alimena, G., Deliliers, G. L., Baratè, C., Specchia, G., Lorenzo, R. D., Luciano, L., et al. (2013) · Leukemia · doi:10.1038/leu.2013.51 · Cited by 152
Porkka, K., Khoury, H. J., PAQUETTE, R. L., Matloub, Y., Sinha, R., & Cortes, J. E. (2009) · Cancer · doi:10.1002/cncr.24734 · Cited by 152
Jabbour, E. J., Kantarjian, H. M., O'Brien, S. M., Shan, J., Quintás‐Cardama, A., Faderl, S. H., Garcia‐Manero, G., Ravandi, F., Rios, M. B., & Cortes, J. E. (2011) · Blood · doi:10.1182/blood-2011-04-348110 · Cited by 151
Melo, J. V. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80003-0 · Cited by 151
Shah, N. P., García‐Gutiérrez, V., Jiménez‐Velasco, A., Larson, S. M., Saußele, S., Réa, D., Mahon, F., Levy, M. Y., Gómez‐Casares, M. T., Pane, F., et al. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1675879 · Cited by 150
Self-citationLaying the foundation for genomically-based risk assessment in chronic myeloid leukemia
on behalf of the International CML Foundation Genomics Alliance, Branford, S., Kim, D. D. H., Apperley, J. F., Eide, C. A., Mustjoki, S., Ong, S. T., Nteliopoulos, G., Ernst, T., Chuah, C., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0512-y · Cited by 149
Jabbour, E. J., Kantarjian, H. M., Jones, D. M., Breeden, M., Garcia‐Manero, G., O'Brien, S. M., Ravandi, F., Borthakur, G. M., & Cortes, J. E. (2008) · Blood · doi:10.1182/blood-2007-11-123950 · Cited by 147
Ross, D. M., Masszi, T., Gómez‐Casares, M. T., Hellmann, A., Stentoft, J., Conneally, E., García‐Gutiérrez, V., Gattermann, N., le Coutre, P. D., Martino, B., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2604-x · Cited by 147
Jabbour, E. J., Kantarjian, H. M., Abruzzo, L. V., O'Brien, S. M., Garcia‐Manero, G., Verstovšek, S., Shan, J., Rios, M. B., & Cortes, J. E. (2007) · Blood · doi:10.1182/blood-2007-01-070045 · Cited by 146
Cirmi, S., Abd, A. E., Létinier, L., Navarra, M., & Salvo, F. (2020) · Cancers · doi:10.3390/cancers12040826 · Cited by 144
Terré, C., Éclache, V., Rousselot, P. H., Imbert, M., Charrin, C., Gervais, C., Mozziconacci, J., Maarek, O., Mossafa, H., Auger, N., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403399 · Cited by 141
for the International BCR-ABL Study Group, Baccarani, M., Castagnetti, F., Gugliotta, G., Rosti, G., Soverini, S., Albeer, A., & Pfirrmann, M. (2019) · Leukemia · doi:10.1038/s41375-018-0341-4 · Cited by 140
Mahon, F., Boquimpani, C. M., Kim, D., Benyamini, N., Clementino, N. C. D., Shuvaev, V. A., Ailawadhi, S., Lipton, J. H., Turkina, A., de Paz, R., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1094 · Cited by 138
Hanfstein, B., Shlyakhto, V., Lauseker, M., Hehlmann, R., Saußele, S., Dietz, C., Erben, P., Fabarius, A. C., Proetel, U., Schnittger, S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.153 · Cited by 137
Naqvi, K., Jabbour, E., Skinner, J., Anderson, K., Dellasala, S., Yilmaz, M., Ferrajoli, A., Bose, P., Thompson, P., Alvarado, Y., et al. (2020) · Cancer · doi:10.1002/cncr.32504 · Cited by 135
Self-citationCortes, J. E., Lipton, J. H., Réa, D., Digumarti, R., Chuah, C. T. H., Nanda, N., Benichou, A., Craig, A. R., Michallet, M., Nicolini, F. E., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415307 · Cited by 134
Jain, P., Kantarjian, H. M., Boddu, P. C., Nogueras‐González, G. M., Verstovšek, S., Garcia‐Manero, G., Borthakur, G. M., Sasaki, K., Kadia, T. M., Sam, P. Y., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018025874 · Cited by 134
The impact of dasatinib on pregnancy outcomes
Cortes, J. E., Abruzzese, E., Chelysheva, E., Guha, M., Wallis, N., & Apperley, J. F. (2015) · American Journal of Hematology · doi:10.1002/ajh.24186 · Cited by 133
Kim, T., Tyndel, M. S., Kim, H. J., Ahn, J.-S., Choi, S. H., Park, H. J., Kim, Y.-K., Kim, S. Y., Lipton, J. H., Zhang, Z., et al. (2017) · Blood · doi:10.1182/blood-2016-04-708560 · Cited by 133
Deininger, M. W., Cortes, J. E., Paquette, R. L., Park, B. S., Hochhaus, A., Baccarani, M., Stone, R. M., Fischer, T., Kantarjian, H. M., Niederwieser, D. W., et al. (2007) · Cancer · doi:10.1002/cncr.22936 · Cited by 132
Self-citationMedina, J., Kantarjian, H., Talpaz, M., O'Brien, S. M., Garcia‐Manero, G., Giles, F. J., Rios, M. B., Hayes, K. J., & Cortes, J. E. (2003) · Cancer · doi:10.1002/cncr.11729 · Cited by 131
Self-citationGiannoudis, A., Davies, A., Lucas, C., Harris, R. J., Pirmohamed, M., & Clark, R. E. (2008) · Blood · doi:10.1182/blood-2007-10-116236 · Cited by 128
Press, R. D., Galderisi, C., Yang, R., Rempfer, C., Willis, S. G., Mauro, M. J., Druker, B. J., & Deininger, M. W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1112 · Cited by 126
Self-citationHanfstein, B., Lauseker, M., Hehlmann, R., Saußele, S., Erben, P., Dietz, C., Fabarius, A. C., Proetel, U., Schnittger, S., Haferlach, C., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.096537 · Cited by 121
Okada, M., Imagawa, J., Tanaka, H., Nakamae, H., Hino, M., Murai, K., Ishida, Y., Kumagai, T., Sato, S., Ohashi, K., et al. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.03.004 · Cited by 120
O'Dwyer, M. E., Mauro, M. J., Blasdel, C., Farnsworth, M., Kurilik, G., Hsieh, Y., Mori, M., & Druker, B. J. (2003) · Blood · doi:10.1182/blood-2003-02-0371 · Cited by 119
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia
Legros, L., Nicolini, F. E., Étienne, G., Rousselot, P. H., Réa, D., Giraudier, S., Guerci‐Bresler, A., Huguet, F., Gardembas, M., Escoffre‐Barbe, M., et al. (2017) · Cancer · doi:10.1002/cncr.30885 · Cited by 115
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase
Kantarjian, H. M., Larson, R. A., Guilhot, F., O’Brien, S. G., Mone, M. D., Rudoltz, M. S., Krahnke, T., Cortes, J. E., Druker, B. J., & for the International Randomized Study of Interferon and STI571 (IRIS) Investigators (2009) · Cancer · doi:10.1002/cncr.24066 · Cited by 114
TYROSINE KINASE INHIBITORS AND PREGNANCY
Abruzzese, E., Trawinska, M. M., de Fabritiis, P., & Perrotti, A. P. (2014) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2014.028 · Cited by 113
Yeung, D. T. O., Osborn, M. P., White, D. L., Branford, S., Braley, J. A., Herschtal, A., Kornhauser, M., Issa, S., Hiwase, D., Hertzberg, M., et al. (2014) · Blood · doi:10.1182/blood-2014-07-590315 · Cited by 113
Aspirin and Reproductive Outcomes
James, A., Brancazio, L. R., & Price, T. M. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31815e8731 · Cited by 112
Cortes, J. E., Khoury, H. J., Kantarjian, H. M., Lipton, J. H., Kim, D., Schafhausen, P., Matczak, E. M., Leip, E. P., Noonan, K., Brümmendorf, T. H., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24536 · Cited by 112
Deininger, M. W., Hodgson, J., Shah, N. P., Cortes, J. E., Kim, D., Nicolini, F. E., Talpaz, M., Baccarani, M., Müller, M. C., Li, J., et al. (2015) · Blood · doi:10.1182/blood-2015-08-660977 · Cited by 110
Self-citationKimura, S. H., Imagawa, J., Murai, K., Hino, M., Kitawaki, T., Okada, M., Tanaka, H., Shindo, M., Kumagai, T., Ikezoe, T., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30235-2 · Cited by 110
Davies, A., Jordanides, N. E., Giannoudis, A., Lucas, C., Hatziieremia, S., Harris, R. J., Jørgensen, H. G., Holyoake, T. L., Pirmohamed, M., Clark, R. E., et al. (2009) · Leukemia · doi:10.1038/leu.2009.166 · Cited by 106
Kantarjian, H. M., Talpaz, M., Cortes, J. E., et al. (2003) · PubMed · Cited by 106
Self-citationHughes, T. P., Laneuville, P., Rousselot, P. H., Snyder, D., Réa, D., Shah, N. P., Paar, D., Abruzzese, E., Hochhaus, A., Lipton, J. H., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.188987 · Cited by 101
Self-citationSoverini, S., Bavaro, L., De Benedittis, C., Martelli, M., Iurlo, A., Orofino, N., Sica, S., Sorà, F., Lunghi, F., Ciceri, F., et al. (2020) · Blood · doi:10.1182/blood.2019002969 · Cited by 100
Russell, M., Carpenter, M. W., Akhtar, M. S., Lagattuta, T. F., & Egorin, M. J. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211665 · Cited by 99
Standardisation of molecular monitoring for chronic myeloid leukaemia
Cross, N. C. P. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.04.001 · Cited by 96
Neelakantan, P., Gerrard, G., Lucas, C., Milojković, D., May, P. C., Wang, L., Paliompeis, C., Bua, M., Reid, A. G., Rezvani, K., et al. (2013) · Blood · doi:10.1182/blood-2012-11-466037 · Cited by 95
Castagnetti, F., Gugliotta, G., Breccia, M., Iurlo, A., Levato, L., Albano, F., Vigneri, P. G., Abruzzese, E., Rossi, G., Rupoli, S., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24774 · Cited by 93
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
for the SAKK and the German CML Study Group, Fabarius, A. C., Kalmanti, L., Dietz, C., Lauseker, M., Rinaldetti, S. L., Haferlach, C., Göhring, G., Schlegelberger, B., Jotterand, M., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2494-9 · Cited by 88
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Soverini, S., Benedittis, C. D., Mancini, M., & Martinelli, G. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.02.035 · Cited by 87
Exposure to hydroxyurea during pregnancy: a case series
Thauvin‐Robinet, C., Maingueneau, C., Robert, E. H., Éléfant, É., Guy, H., Caillot, D., Casasnovas, O., Douvier, S., & Nivelon‐Chevallier, A. (2001) · Leukemia · doi:10.1038/sj.leu.2402168 · Cited by 86
Managing pregnancy in chronic myeloid leukaemia
Palani, R., Milojković, D., & Apperley, J. F. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2317-z · Cited by 86
Tefferi, A., & Letendre, L. (2011) · American Journal of Hematology · doi:10.1002/ajh.22051 · Cited by 86
Seong, D., Kantarjian, H., Ro, J. Y., Talpaz, M., Xu, J., Robinson, J., Deisseroth, A., Champlin, R., & Siciliano, M. (1995) · Blood · doi:10.1182/blood.v86.6.2343.bloodjournal8662343 · Cited by 84
Self-citationImatinib use during pregnancy and breast feeding: a case report and review of the literature
Ali, R., Özkalemkaş, F., Kímya, Y., Köksal, N., Özkocaman, V., Gülten, T., Yorulmaz, H., & Tunalı, A. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0861-7 · Cited by 82
Testoni, N., Marzocchi, G., Luatti, S., Amabile, M., Baldazzi, C., Stacchini, M., Nanni, M., Rege‐Cambrin, G., Giugliano, E., Giussani, U., et al. (2009) · Blood · doi:10.1182/blood-2009-07-229864 · Cited by 81
on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), Ross, D. M., Pagani, I. S., Shanmuganathan, N., Kok, C. H., Seymour, J. F., Mills, A. K., Filshie, R., Arthur, C. K., Dang, P., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0264-0 · Cited by 81
A multiplex PCR for improved detection of typical and atypical BCR–ABL fusion transcripts
Burmeister, T., & Reinhardt, R. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.08.017 · Cited by 80
Jabbour, E. J., Kantarjian, H. M., Jones, D. M., Reddy, N., O'Brien, S. M., Garcia‐Manero, G., Burger, J. A., & Cortes, J. E. (2008) · Blood · doi:10.1182/blood-2008-04-149948 · Cited by 79
Soverini, S., Abruzzese, E., Bocchia, M., Bonifacio, M., Galimberti, S., Gozzini, A., Iurlo, A., Luciano, L., Pregno, P., Rosti, G., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0815-5 · Cited by 79
Press, R. D., Willis, S. G., Laudadio, J., Mauro, M. J., & Deininger, M. W. (2009) · Blood · doi:10.1182/blood-2008-08-173674 · Cited by 78
Self-citationJabbour, E. J., Kantarjian, H. M., O'Brien, S. M., Shan, J., Quintás‐Cardama, A., Garcia‐Manero, G., Rios, M. B., & Cortes, J. E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.0693 · Cited by 78
Marín, D., Goldman, J. M., Olavarría, E., et al. (2003) · Blood · doi:10.1182/blood-2003-06-2042 · Cited by 77
Nicolini, F. E., Hayette, S., Corm, S., Bachy, E., Bories, D., Tulliez, M., Guilhot, F., Legros, L., Maloisel, F., Kiladjian, J., et al. (2007) · Haematologica · doi:10.3324/haematol.11369 · Cited by 74
Issa, G. C., Kantarjian, H. M., González, G. N., Borthakur, G. M., Tang, G., Wierda, W. G., Sasaki, K., Short, N. J., Ravandi, F., Kadia, T. M., et al. (2017) · Blood · doi:10.1182/blood-2017-07-792143 · Cited by 74
New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia
Westerweel, P. E., Boekhorst, P. A. W. T., Levin, M., & Cornelissen, J. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00665 · Cited by 73
Bouchet, S., Titier, K., Moore, N. D., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12007 · Cited by 72
Thielen, N., van der Holt, B., Cornelissen, J. J., Verhoef, G. E. G., Gussinklo, T., Biemond, B. J., Daenen, S. M. G. J., Deenik, W., Kooy, R. V. M., Petersen, E. J., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.018 · Cited by 71
Kim, S.-H., Menon, H., Jootar, S., Saikia, T., Kwak, J., Sohn, S. K., Park, J. S., Jeong, S. H., Kim, H., Kim, Y.-K., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.096776 · Cited by 71
Orlandi, E. M., Rocca, B., Pazzano, A. S., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.08.007 · Cited by 70
Wang, W., Cortes, J. E., Lin, P., Beaty, M. W., Ai, D., Amin, H. M., McDonnell, T. J., Ok, C. Y., Kantarjian, H. M., Medeiros, L. J., et al. (2015) · Blood · doi:10.1182/blood-2015-05-646489 · Cited by 69
Kantarjian, H. M., Shan, J., Jones, D. M., O'Brien, S. M., Rios, M. B., Jabbour, E. J., & Cortes, J. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6999 · Cited by 68
Gambacorti-Passerini, C. B., Cortes, J. E., Lipton, J. H., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.171249 · Cited by 68
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia
Adnan Awad, S., Kankainen, M., Ojala, T., Koskenvesa, P., Eldfors, S., Ghimire, B., Kumar, A., Kytölä, S., Kamel, M. M., Heckman, C. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000943 · Cited by 67
Wu, E. Q., Guérin, A., Yu, A. P., Bollu, V. K., Guo, A. X., & Griffin, J. D. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.533648 · Cited by 66
Deininger, M. W., Kopecky, K. J., Radich, J. P., Kamel‐Reid, S., Stock, W., Paietta, E. M., Emanuel, P. D., Tallman, M. S., Wadleigh, M., Larson, R. A., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12618 · Cited by 65
Self-citationSeymour, J. F., Kim, D. W., Rubin, E., Haregewoin, A., Clark, J., Watson, P., Hughes, T. P., Dufva, I. H., Jiménez, J. L., Mahon, F., et al. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.60 · Cited by 65
Cortes, J. E., Digumarti, R., Parikh, P. M., Wetzler, M., Lipton, J. H., Hochhaus, A., Craig, A. R., Benichou, A., Nicolini, F. E., Kantarjian, H. M., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23408 · Cited by 65
Verma, D., Kantarjian, H. M., Shan, J., O'Brien, S. M., Estrov, Z. E., Garcia‐Manero, G., Koller, C. A., Borthakur, G. M., & Cortes, J. E. (2010) · Cancer · doi:10.1002/cncr.25015 · Cited by 64
Cervantes, F., López-Garrido, P., Montero, M.-I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.021154 · Cited by 64
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
Massimino, M., Stella, S., Tirrò, E., Romano, C., Pennisi, M. S., Puma, A., Manzella, L., Zanghì, A., Stagno, F., Raimondo, F. D., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0805-1 · Cited by 64
Quintás‐Cardama, A., Kantarjian, H. M., O'Brien, S. M., et al. (2004) · Cancer · doi:10.1002/cncr.20285 · Cited by 63
Wang, L., Knight, K., Lucas, C., & Clark, R. E. (2006) · PubMed · Cited by 61
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
Togasaki, E., Takeda, J., Yoshida, K., Shiozawa, Y., Takeuchi, M., Oshima, M., Saraya, A., Iwama, A., Yokote, K., Sakaida, E., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.36 · Cited by 61
On behalf of the TOPS investigators, Baccarani, M., Druker, B. J., et al. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1566-2 · Cited by 60
Borthakur, G. M., Dombret, H., Schafhausen, P., Brümmendorf, T. H., Boissel, N., Jabbour, E., Mariani, M., Capolongo, L., Carpinelli, P., Davite, C., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.115279 · Cited by 60
Kizilors, A., Crisà, E., Lea, N. C., Passera, R., Mian, S. A., Anwar, J., Best, S., Nicolini, F. E., Ireland, R. M., Aldouri, M., et al. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30027-4 · Cited by 58
The use of low-molecular-weight heparins in pregnancy – how safe are they?
Deruelle, P., & Coulon, C. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f10e33 · Cited by 56
Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
Gong, Z., Medeiros, L. J., Cortes, J. E., Zheng, L., Khoury, J. D., Wang, W., Tang, G., Loghavi, S., Luthra, R., Yang, W., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.62 · Cited by 56
Sweet, K. L., Hazlehurst, L., Sahakian, E., Powers, J. J., Nodzon, L., Kayali, F., Hyland, K. A., Nelson, A. M., & Pinilla-Ibarz, J. A. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.10.002 · Cited by 56
Self-citationAlhuraiji, A., Kantarjian, H. M., Boddu, P. C., Ravandi, F., Borthakur, G. M., Dinardo, C. D., Daver, N. G., Kadia, T. M., Pemmaraju, N., Pierce, S. A., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24943 · Cited by 53
Cortes, J. E., Jabbour, E. J., Daley, G. Q., O'Brien, S. M., Verstovšek, S., Ferrajoli, A., Koller, C. A., Zhu, Y., Statkevich, P., & Kantarjian, H. M. (2007) · Cancer · doi:10.1002/cncr.22901 · Cited by 52
Cornelison, M., Jabbour, E. J., & Welch, M. A. (2012) · The Journal of Supportive Oncology · doi:10.1016/j.suponc.2011.08.001 · Cited by 50
Iriyama, N., Fujisawa, S., Yoshida, C., Wakita, H., Chiba, S., Okamoto, S., Kawakami, K., Takezako, N., Kumagai, T., Inokuchi, K., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23923 · Cited by 48
Guérin, A., Chen, L., Dea, K., Wu, E. Q., & Goldberg, S. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.904281 · Cited by 48
Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy
Ramasamy, K., Hayden, J., Lim, Z., Mufti, G. J., & Ho, A. Y. L. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06542.x · Cited by 46
Knickerbocker, R. K., Dorer, D. J., Haluska, F. G., Baccarani, M., Cortes, J. E., Hochhaus, A., & Talpaz, M. (2014) · Blood · doi:10.1182/blood.v124.21.4546.4546 · Cited by 46
Self-citationFabarius, A. C., Haferlach, C., Muller, M. C., Erben, P., Lahaye, T., Giehl, M., Frank, O., Seifarth, W., Hehlmann, R., & Hochhaus, A. (2007) · Haematologica · doi:10.3324/haematol.11064 · Cited by 45
Cortes, J. E., Quintás‐Cardama, A., Garcia‐Manero, G., O'Brien, S. M., Jones, D. M., Faderl, S. H., Ebarb, T., Giles, F. J., Thomas, D. A., & Kantarjian, H. M. (2007) · Cancer · doi:10.1002/cncr.23006 · Cited by 45
Pfirrmann, M., Evtimova, D., Saußele, S., Castagnetti, F., Cervantes, F., Janssen, J. J. W. M., Hoffmann, V. S., Gugliotta, G., Hehlmann, R., Hochhaus, A., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2321-2 · Cited by 45
Quintás‐Cardama, A., Santos, F. P. D. S., Kantarjian, H. M., O'Brien, S. M., Faderl, S. H., Awais, A., Borthakur, G. M., & Cortes, J. E. (2009) · Cancer · doi:10.1002/cncr.24432 · Cited by 43
Yood, M. U., Oliveria, S. A., Cziraky, M. J., Hirji, I., Hamdan, M., & Davis, C. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.649849 · Cited by 42
Cortes, J. E., Souza, C. A. D., Ayala, M., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30167-3 · Cited by 42
Kantarjian, H. M., & Cortes, J. E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9176 · Cited by 40
Frequency of rare BCR ‐ ABL 1 fusion transcripts in chronic myeloid leukemia patients
Arunachalam, A. K., Anandan, S., Mani, S., Kumaraswamy, V., Arthur, N. B. J., Lakshmi, K. M., Abraham, A., George, B., Srivastava, A., Srivastava, V. M., et al. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12616 · Cited by 39
Feldman, E. J., Najfeld, V., Schuster, M. K., Roboz, G. J., Chadburn, A., & Silver, R. T. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00176-0 · Cited by 38
Cortes, J. E., Lipton, J. H., Miller, C. B., Busque, L., Akard, L. P., Pinilla-Ibarz, J. A., Keir, C. H., Warsi, G. M., Lin, F. P., & Mauro, M. J. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.02.002 · Cited by 38
Nazha, A., Kantarjian, H. M., Jain, P., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.090282 · Cited by 35
Navarro, J., Feliú, E., Grau, J., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.20859 · Cited by 34
Lima, L. M., Bernal‐Mizrachi, L., Saxe, D., et al. (2010) · Cancer · doi:10.1002/cncr.25678 · Cited by 34
Cited by
Arber, D. A., Orazi, A., Hasserjian, R. P., Borowitz, M. J., Calvo, K. R., Kvasnicka, H.-M., Wang, S. A., Bagg, A., Barbui, T., Branford, S., et al. (2022) · Blood · doi:10.1182/blood.2022015850 · Cited by 2,945
Self-citationAlves, R., Gonçalves, A. C., Rutella, S., Almeida, A. M., De Las Rivas, J., Trougakos, I. P., & Sarmento Ribeiro, A. B. (2021) · Cancers · doi:10.3390/cancers13194820 · Cited by 204
Jiang, Q., Li, Z., Qin, Y., Li, W., Xu, N., Liu, B., Zhang, Y., Meng, L., Zhu, H., Du, X., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01334-z · Cited by 102
Self-citationBidikian, A., Jabbour, E., Issa, G. C., Short, N. J., Sasaki, K., & Kantarjian, H. (2023) · American Journal of Hematology · doi:10.1002/ajh.26836 · Cited by 32
Gener-Ricos, G., Haddad, F. G., Sasaki, K., Issa, G. C., Skinner, J., Masarova, L., Borthakur, G., Alvarado, Y., Garcia-Manero, G., Jabbour, E., et al. (2023) · Clinical Lymphoma Myeloma and Leukemia · doi:10.1016/j.clml.2023.05.009 · Cited by 30
Metadata
- Authors
- Deininger, M. W., Shah, N. P., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., DeAngelo, D. J., Gotlib, J., Hobbs, G., Maness, L., Mead, M., Metheny, L., Mohan, S., Moore, J. O., Naqvi, K., Oehler, V., Pallera, A. M., Patnaik, M., Pratz, K., Pusic, I., Rose, M. G., Smith, B. D., Snyder, D. S., Sweet, K. L., Talpaz, M., Thompson, J., Yang, D. T., Gregory, K. M., & Sundar, H.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2020-10
- Volume
- 18
- Issue
- 10
- Pages
- 1385-1415
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3092607363
- Cited by
- 262
- References
- 236
- FWCI
- 24.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.